Q1 EPS Estimates for Core Scientific Reduced by Roth Capital

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Research analysts at Roth Capital lowered their Q1 2025 EPS estimates for Core Scientific in a report released on Wednesday, April 9th. Roth Capital analyst D. Aftahi now expects that the company will earn ($0.14) per share for the quarter, down from their prior forecast of ($0.11). The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific's Q2 2025 earnings at ($0.12) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.43) EPS and Q1 2026 earnings at ($0.02) EPS.

Core Scientific (NASDAQ:CORZ - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.10) by $0.09. The business had revenue of $94.93 million during the quarter, compared to analysts' expectations of $97.07 million.

CORZ has been the topic of a number of other reports. Needham & Company LLC cut their price target on Core Scientific from $18.00 to $17.00 and set a "buy" rating on the stock in a report on Thursday, February 27th. Cantor Fitzgerald decreased their price target on shares of Core Scientific from $24.00 to $21.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Keefe, Bruyette & Woods assumed coverage on shares of Core Scientific in a research note on Monday, January 27th. They issued an "outperform" rating and a $22.00 target price for the company. HC Wainwright restated a "buy" rating and set a $17.00 target price on shares of Core Scientific in a research note on Tuesday, March 11th. Finally, BTIG Research upped their price objective on shares of Core Scientific from $19.00 to $20.00 and gave the company a "buy" rating in a report on Monday, December 16th. Fifteen analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Core Scientific has a consensus rating of "Buy" and an average target price of $19.07.

Remove Ads

Core Scientific Trading Down 3.0 %

Shares of Core Scientific stock traded down $0.21 during trading on Monday, hitting $6.85. 9,966,720 shares of the stock traded hands, compared to its average volume of 12,389,732. Core Scientific has a 52-week low of $2.61 and a 52-week high of $18.63. The stock's fifty day simple moving average is $9.28 and its 200 day simple moving average is $12.69. The firm has a market cap of $2.02 billion, a P/E ratio of -1.27 and a beta of 6.80.

Insider Buying and Selling at Core Scientific

In other news, CEO Adam Taylor Sullivan sold 369,712 shares of the company's stock in a transaction that occurred on Friday, January 24th. The shares were sold at an average price of $16.24, for a total value of $6,004,122.88. Following the transaction, the chief executive officer now directly owns 3,758,793 shares in the company, valued at approximately $61,042,798.32. This represents a 8.96 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Todd M. Duchene sold 25,277 shares of the firm's stock in a transaction dated Friday, January 24th. The shares were sold at an average price of $16.24, for a total value of $410,498.48. Following the transaction, the insider now owns 2,023,423 shares of the company's stock, valued at $32,860,389.52. This trade represents a 1.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 530,041 shares of company stock worth $7,870,352 in the last ninety days. 32.00% of the stock is owned by insiders.

Institutional Investors Weigh In On Core Scientific

Hedge funds have recently added to or reduced their stakes in the business. Wellington Shields & Co. LLC acquired a new position in Core Scientific during the 4th quarter worth $26,000. First Horizon Advisors Inc. purchased a new stake in Core Scientific during the 4th quarter worth about $34,000. Newbridge Financial Services Group Inc. purchased a new position in shares of Core Scientific in the 4th quarter valued at about $42,000. GAMMA Investing LLC raised its position in shares of Core Scientific by 1,722.3% during the 1st quarter. GAMMA Investing LLC now owns 8,565 shares of the company's stock worth $62,000 after acquiring an additional 8,095 shares in the last quarter. Finally, Vestcor Inc acquired a new position in Core Scientific in the fourth quarter valued at approximately $66,000.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.